Emergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
J Emerg Med. 2022 Apr;62(4):443-454. doi: 10.1016/j.jemermed.2021.10.046. Epub 2021 Nov 3.
There is a lack of knowledge about the real incidence of acute coronary syndrome (ACS) in patients with COVID-19, their clinical characteristics, and their prognoses.
We investigated the incidence, clinical characteristics, risk factors, and outcomes of ACS in patients with COVID-19 in the emergency department.
We retrospectively reviewed all COVID-19 patients diagnosed with ACS in 62 Spanish emergency departments between March and April 2020 (the first wave of COVID-19). We formed 2 control groups: COVID-19 patients without ACS (control A) and non-COVID-19 patients with ACS (control B). Unadjusted comparisons between cases and control subjects were performed regarding 58 characteristics and outcomes.
We identified 110 patients with ACS in 74,814 patients with COVID-19 attending the ED (1.48% [95% confidence interval {CI} 1.21-1.78%]). This incidence was lower than that observed in non-COVID-19 patients (3.64% [95% CI 3.54-3.74%]; odds ratio [OR] 0.40 [95% CI 0.33-0.49]). The clinical characteristics of patients with COVID-19 associated with a higher risk of presenting ACS were: previous coronary artery disease, age ≥60 years, hypertension, chest pain, raised troponin, and hypoxemia. The need for hospitalization and admission to intensive care and in-hospital mortality were higher in cases than in control group A (adjusted OR [aOR] 6.36 [95% CI 1.84-22.1], aOR 4.63 [95% CI 1.88-11.4], and aOR 2.46 [95% CI 1.15-5.25]). When comparing cases with control group B, the aOR of admission to intensive care was 0.41 (95% CI 0.21-0.80), while the aOR for in-hospital mortality was 5.94 (95% CI 2.84-12.4).
The incidence of ACS in patients with COVID-19 attending the emergency department was low, around 1.48%, but could be increased in some circumstances. Patients with COVID-19 with ACS had a worse prognosis than control subjects with higher in-hospital mortality.
关于 COVID-19 患者中急性冠状动脉综合征(ACS)的实际发生率、临床特征及其预后,人们知之甚少。
我们调查了急诊科 COVID-19 患者中 ACS 的发生率、临床特征、危险因素和结局。
我们回顾性分析了 2020 年 3 月至 4 月间西班牙 62 家急诊科诊断为 ACS 的所有 COVID-19 患者(COVID-19 疫情的第一波)。我们设立了 2 个对照组:无 ACS 的 COVID-19 患者(对照组 A)和非 COVID-19 患者伴 ACS(对照组 B)。对病例和对照组之间 58 个特征和结局进行了未调整比较。
我们在急诊科就诊的 74814 例 COVID-19 患者中发现 110 例 ACS(1.48%[95%可信区间 1.21-1.78%])。这一发生率低于非 COVID-19 患者(3.64%[95%CI 3.54-3.74%];比值比[OR]0.40[95%CI 0.33-0.49])。与 COVID-19 患者 ACS 发生率升高相关的临床特征为:既往冠状动脉疾病、年龄≥60 岁、高血压、胸痛、肌钙蛋白升高和低氧血症。与对照组 A 相比,病例组需要住院、入住重症监护病房和院内死亡的比例更高(校正比值比[aOR]6.36[95%CI 1.84-22.1]、aOR 4.63[95%CI 1.88-11.4]和 aOR 2.46[95%CI 1.15-5.25])。与对照组 B 相比,病例组入住重症监护病房的 aOR 为 0.41(95%CI 0.21-0.80),而院内死亡率的 aOR 为 5.94(95%CI 2.84-12.4)。
急诊科就诊 COVID-19 患者 ACS 的发生率较低,约为 1.48%,但在某些情况下可能会升高。COVID-19 伴 ACS 的患者预后较对照组差,院内死亡率更高。